[ASSOCIATION OF 4,4'-DIISOAMYLOXYTHIOCARBANILIDE AND PYRAZINAMIDE, AND 4,4'-DIISOAMYLOXYTHIOCARBANILIDE AND KANAMYCIN IN THE TREATMENT OF PULMONARY TUBERCULOSIS CAUSED BY BACTERIA RESISTANT TO THE 1ST LINE DRUGS].
D000995:Antitubercular Agents; D001419:Bacteria; D001432:Bacteriology; D004351:Drug Resistance; D004352:Drug Resistance, Microbial; D007612:Kanamycin; D010670:Phenylthiourea / Q000031:analogs & derivatives; D011718:Pyrazinamide; D013902:Radiography, Thoracic; D013183:Sputum; D014116:Toxicology; D014397:Tuberculosis, Pulmonary
D000995:Antitubercular Agents; D011718:Pyrazinamide; C100189:thiocarlide; D007612:Kanamycin; D010670:Phenylthiourea
ANTITUBERCULAR AGENTS; BACTERIOLOGY; DRUG RESISTANCE, MICROBIAL; KANAMYCIN; PYRAZINAMIDE; SPUTUM; THIOCARLIDE; THORACIC RADIOGRAPHY; TOXICOLOGIC REPORT; TUBERCULOSIS, PULMONARY
ASOCIACI'ON 4-4' DIISOAMILOXITIOCARBANILIDA-PIRAZINAMIDA Y 4-4' DIISOAMILOXITIOCARBANILIDA-KANAMICINA EN EL TRATAMIENTO DE LA TUBERCULOSIS PULMONAR CON G'ERM'ENES RESISTENTES A LAS DROGAS "MAYORES".